Trade XAIR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Beyond Air, Inc. (XAIR) is trading at US$3.20, up 4.23% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$4.96M. Over the past 52 weeks, XAIR has traded between US$3.06 and US$55.60. On Syfe you can trade XAIR with $0 commission and add it to your watchlist.
| Previous close | US$3.07 |
|---|---|
| Market cap | US$4.96M |
| 52-week range | US$3.06 – US$55.60 |
| Volume | 64.46K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Beyond Air, Inc.
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air, Beyond Cancer segments, and NeuroNos. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Year: 2016
Beyond Air to Raise Up to $30.1 Million in Private Placement
Jul 30, 2:44 PM · MT Newswires
Beyond Air CEO Steve Lisi Resigns; COO to Succeed
Mar 26, 8:37 PM · MT Newswires
Beyond Air, Inc. (XAIR) stock is trading at US$3.20, +4.23% from the previous close of US$3.07.
The market cap for Beyond Air, Inc. (XAIR) stock is approximately US$4.96M.
The 52-week high for Beyond Air, Inc. (XAIR) stock is US$55.60.
The 52-week low for Beyond Air, Inc. (XAIR) stock is US$3.06.
Beyond Air, Inc. (XAIR) does not currently pay a dividend.
Stay on top of XAIR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
